UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in SPRY — ARS Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in SPRY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,731,387
+$184,604 QoQ
Shares Held
464,681
+52.6% QoQ
Ownership
0.468%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
12 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. SPRY ranks #79 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in SPRY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,731,387 | 464,681 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,546,783 | 304,445 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,368,237 | 335,148 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,682,504 | 325,645 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,520,386 | 279,840 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,609,162 | 247,314 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,400,786 | 234,537 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $230,459 | 27,081 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $132,246 | 12,940 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $70,911 | 12,940 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $48,913 | 12,940 | Shares | Defined | 2023-11-13 | |
| 2020-12-31 | $2,668,025 | 57,575 | Shares | Defined | 2021-03-01 | |
| No filing history on record for this holder in this stock. | ||||||